AC
CELG

Avestar Capital’s Celgene Corp CELG Stock Holding History

Avestar Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-603
Closed -$53K – 984
2019
Q2 		$53K Buy
603
+5
+0.8% +$475 0.03% 282
2019
Q1 		$54K Sell
598
-1,857
-76% -$162K 0.04% 276
2018
Q4 		$136K Sell
2,455
-448
-15% -$33.1K 0.09% 133
2018
Q3 		$238K Buy
2,903
+178
+7% +$15.7K 0.14% 97
2018
Q2 		$197K Buy
2,725
+214
+9% +$17.8K 0.12% 106
2018
Q1 		$203K Buy
2,511
+645
+35% +$61.9K 0.13% 91
2017
Q4 		$175K Buy
+1,866
New +$211K 0.13% 91

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Avestar Capital's CELG Position: Q3 2019 in Review

Avestar Capital sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 603 shares — an estimated $53K sold.

Avestar Capital first reported a position in CELG in Q4 2017 and held it in 7 quarters. The position peaked at $238K in Q3 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Avestar Capital reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Avestar Capital sold 603 Celgene Corp shares in Q3 2019, an estimated $53K.
  • Avestar Capital first reported a position in Celgene Corp in Q4 2017 and held it in 7 quarters.
  • Avestar Capital's Celgene Corp position peaked at $238K in Q3 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.